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From the *Cardiac Unit, Santorso Hospital, Santorso, Italy, and †Ferrara Medical School, Ferrara, Italy.Figure 1 Electrocardiogram taken just after cardiac deﬁbrillation. The traces show sinus rhythm and a resemblance to a type 1 pattern.Introduction
Aborted sudden cardiac death (SCD) occurred in a previ-
ously asymptomatic 58-year-old woman with mitral valve
prolapse. Electrocardiogram (ECG) soon after deﬁbrillation
and after ﬂecainide challenge was consistent with type 1
Brugada pattern. Contrast magnetic resonance imaging
(MRI) study of the left ventricle showed a delayed enhance-
ment (suggesting ﬁbrosis) of the inferior-basal left ventric-
ular wall at the insertion of the posterior papillary muscle.
Two lethal conditions, never reported before to occur
together, affected this patient.Case report
A 58-year-old woman suffered cardiac arrest while serving a
client at her shop. Resuscitation maneuvers were performed
by a friend and ventricular ﬁbrillation was documented andKEYWORDS Ventricular ﬁbrillation; Brugada syndrome; Mitral valve pro-
lapse; Sudden cardiac death; Channelopathies; Arrhythmogenic right
ventricular dysplasia/cardiomyopathy
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).promptly terminated by a DC shock delivered by a mobile
emergency medical unit. After a brief period of atrial
ﬁbrillation, sinus rhythm spontaneously resumed and a 12-
lead ECG showed a transient late coved wave in V1-V2
(Figure 1). The patient was treated with hypothermia (331C)
for 2 days and totally recovered. The ECG showed some
minor late coved wave during cooling and returned to a
persistent normal pattern after warming. A ﬂecainide chal-
lenge test (2 mg/kg injected over 10 minutes) was performed
5 days after the aborted cardiac arrest and resulted in a
Brugada type 1 ECG pattern with late QRS fragmentation in
V1 but no S wave in lead 1 (Figure 2). The patient’s past
history revealed a diagnosis of mitral valve prolapse (MVP)
at 21 years of age with curling and moderate regurgitation,
yearly normal ECGs, and the presence of late potentials
during signal-averaged ECG. There was no history of
syncope or signiﬁcant ventricular arrhythmias on repeated
Holter monitoring: only isolated ventricular premature con-
tractions (VPCs), of both right bundle branch block and left
bundle branch block morphology, could be determined. The
patient’s mother also suffered from MVP with signiﬁcant
mitral regurgitation, for which she underwent surgical repair
at age 78. There was no family history of SCD or abnormal
ECG patterns. Myocarditis and different channelopathiespen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.08.013
KEY TEACHING POINTS
 Ventricular ﬁbrillation can be due to Brugada
syndrome and to mitral valve prolapse.
 An association of the 2 syndromes in the same
patient is exceptional.
 Probably 1 of the conditions is an incidentaloma.
Heart Rhythm Case Reports, Vol 0, No 0, Month 20162were excluded, as well as short-coupled torsades de pointes.
The patient underwent comprehensive cardiac workup, as
per our protocol in similar cases, which is devoted to
investigating latent structural heart disease. At cardiac
angiography no signiﬁcant structural or wall motion abnor-
malities of either ventricle were detected, in particular
arrhythmogenic cardiomyopathy. Only a slight derangement
of the trabecular pattern was noted. The right ventricular
outﬂow tract was normal. A patchy ﬁbrosis of the inferobasal
wall of the left ventricle, at the insertion of the papillary
muscle, was ascertained by contrast-enhanced cardiac MRI
(Figure 3). The patient was successfully implanted with a
subcutaneous implantable cardioverter-deﬁbrillator (ICD).
Genetic studies are currently pending. Considering the
absence of any familial history of ECG feature, we do not
expect any new information from this study. No arrhythmias
have recurred during a follow-up of 3 months after ICD
implantation.
Discussion
This healthy and previously asymptomatic woman could
have died because of Brugada syndrome (BrS)1 or malignant
MVP.2 As MVP prevalence reaches 3% in the generalFigure 2 Flecainide challenge. a: At baseline electrocardiogram (ECG) with rig
axis deviation is present, but not type 1 ECG. b:After ﬂecainide a type 1 ECG is pre
at the third intercostal space. d: After ﬂecainide with V1-V2 placed at the secondpopulation it is difﬁcult to exclude a chance association,
and recent data identify a subgroup of patients with ECG and
ﬁbrotic changes at high risk of SCD.2 The estimated rate of
SCD in MVP ranges from 0.2% to 0.4%/year.2 Some
controversy exists on the rate of SCD in BrS, as most of
the patients have not a true syndrome but an asymptomatic
ECG abnormality, either spontaneous or drug induced.3 In
this latter group, an annual rate of 0.5%, higher in those with
a spontaneous type 1 ECG, was reported.4 An organic
cardiac structural heart disease is nowadays considered a
substrate in both situations, although it was initially debated
in BrS.5,6 In malignant MVP localized ﬁbrosis is present at
the inferobasal portion of the left ventricular wall where early
electrophysiological studies demonstrated the most common
site of origin of ventricular premature beats.7 In BrS a
localized ﬁbrosis of the right ventricular outﬂow tract, which
induces conduction disturbances and possibly also some
repolarization abnormalities, is assumed to be responsible for
the lethal arrhythmias.8 The origin of this common histologic
abnormality could be the excessive traction on the papillary
muscle by the MVP2 and some acquired genetic or embryo-
logic abnormality in BrS.9 In our patient both electrical and
structural abnormalities were present. There are several
arguments suggesting MVP as the cause of the event: (1)
female sex; (2) signiﬁcant MVP with “curling” and ﬁbrosis
of the inferior left ventricle at MRI; (3) isolated VPCs mostly
of right bundle branch block morphology; (4) family history
of severe MVP. Against this hypothesis the patient’s ECG
did not show marked repolarization changes in the inferior
leads. In contrast, several arguments support the diagnosis of
BrS: (1) according to Sacher,10 age and the absence of
spontaneous ECG pattern; (2) similar ECG pattern soon after
resuscitation, and type 1 after ﬂecainide test, with a markedht precordial leads V1-V2 placed at the fourth intercostal space. Marked left
sent with some late QRS fragmentation. c:After ﬂecainide with V1-V2 placed
intercostal space.
Figure 3 Contrast magnetic resonance imaging study of the left ventricle: delayed enhancement (suggesting ﬁbrosis) of the inferior-basal left ventricular wall
at the insertion of the posterior papillary muscle (arrow).
3Martini et al Association of Brugada Syndrome and Mitral Valve Prolapselate coved wave in V1; (3) positive late potentials; (4) some
derangement of right ventricular trabecular pattern at angiog-
raphy; (5) occurrence of ventricular ﬁbrillation during
normal activities; (6) isolated VPCs of left bundle branch
block morphology at Holter monitoring.
In our opinion, it is actually impossible to establish what
is the true cause of this aborted case of sudden death and
what could be an alternative therapeutic approach.11,12 In
general most patients with an inducible Brugada pattern
receive an ICD at that point, and do not have further
investigations, which in our experience are still necessary
to better understand these rare conditions.
Conclusion
SCD is always linked to a lethal electrical abnormality with
both organic and functional components. When, unfortu-
nately, not 1 but 2 rare and lethal situations coexist, it is
difﬁcult even for expert specialists to determine which is the
killer and which is the silent bystander.
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